CD24 is Significantly Involved in Pancreatic Cancer Progression by Targeting Focal Adhesion Molecules and Regulating Cell Functions

被引：0
|
作者：
Otifi, H. O. [1 ]
Ilyas, M. I. [1 ]
机构：
[1] Univ Nottingham, Nottingham, England
来源：
JOURNAL OF PATHOLOGY | 2016年 / 240卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 22 条
  • [11] A multifunctional antibody fusion protein 57103 targeting CD24, IL-4R, and αvβ3 for treating cancer and regulating the tumor microenvironment
    Xu, Xiaowei
    Li, Jian
    Setrerrahmane, Sarra
    Zhang, Juan
    Shi, Suoqin
    Hu, Yahui
    Lin, Dong
    Xu, Hanmei
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [12] Targeting CD24 Enhances the Response to ThirdGeneration Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer
    Liang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S79 - S79
  • [13] Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis (vol 2017, 3276806, 2017)
    Durko, L.
    Wlodarski, W.
    Stasikowska-Kanicka, O.
    Wagrowska-Danilewicz, M.
    Danilewicz, M.
    Hogendorf, P.
    Strzelczyk, J.
    Malecka-Panas, E.
    DISEASE MARKERS, 2017, 2017
  • [14] ADHESIVE HIERARCHY INVOLVING THE CELL-ADHESION MOLECULES L1, CD24, AND ALPHA-6 INTEGRIN IN MURINE NEUROBLASTOMA N2A CELLS
    KADMON, G
    IMHOF, BA
    ALTEVOGT, P
    SCHACHNER, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 214 (01) : 94 - 101
  • [15] HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24
    W W Teo
    V F Merino
    S Cho
    P Korangath
    X Liang
    R-c Wu
    N M Neumann
    A J Ewald
    S Sukumar
    Oncogene, 2016, 35 : 5539 - 5551
  • [16] HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24
    Teo, W. W.
    Merino, V. F.
    Cho, S.
    Korangath, P.
    Liang, X.
    Wu, R-C
    Neumann, N. M.
    Ewald, A. J.
    Sukumar, S.
    ONCOGENE, 2016, 35 (42) : 5539 - 5551
  • [17] Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
    Valeria Pecci
    Fabiola Troisi
    Aurora Aiello
    Sara De Martino
    Angela Carlino
    Vincenzo Fiorentino
    Cristian Ripoli
    Dante Rotili
    Francesco Pierconti
    Maurizio Martini
    Manuela Porru
    Francesco Pinto
    Antonello Mai
    Pier Francesco Bassi
    Claudio Grassi
    Carlo Gaetano
    Alfredo Pontecorvi
    Lidia Strigari
    Antonella Farsetti
    Simona Nanni
    Cancer Cell International, 24
  • [18] Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
    Pecci, Valeria
    Troisi, Fabiola
    Aiello, Aurora
    De Martino, Sara
    Carlino, Angela
    Fiorentino, Vincenzo
    Ripoli, Cristian
    Rotili, Dante
    Pierconti, Francesco
    Martini, Maurizio
    Porru, Manuela
    Pinto, Francesco
    Mai, Antonello
    Bassi, Pier Francesco
    Grassi, Claudio
    Gaetano, Carlo
    Pontecorvi, Alfredo
    Strigari, Lidia
    Farsetti, Antonella
    Nanni, Simona
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [19] CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer
    Ooki, Akira
    VandenBussche, Christopher J.
    Kates, Max
    Hahn, Noah M.
    Matoso, Andres
    McConkey, David J.
    Bivalacqua, Trinity J.
    Hoque, Mohammad Obaidul
    BRITISH JOURNAL OF CANCER, 2018, 119 (08) : 961 - 970
  • [20] CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer
    Akira Ooki
    Christopher J. VandenBussche
    Max Kates
    Noah M. Hahn
    Andres Matoso
    David J. McConkey
    Trinity J. Bivalacqua
    Mohammad Obaidul Hoque
    British Journal of Cancer, 2018, 119 : 961 - 970
123